-
161
Week 96 Results of Switching from Tenofovir Disoproxil Fumarate-Based Antiretroviral Therapy to Coformulated Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide among HIV/Hepatitis B Virus-Coinfected Patients
Published 2023-06-01“…ABSTRACT Data regarding the durability of tenofovir alafenamide (TAF)-containing antiretroviral therapy (ART) in maintaining hepatitis B virus (HBV) viral suppression among HIV/HBV-coinfected patients are limited. …”
Get full text
Article -
162
Nuevos tratamientos para el manejo de la Hepatitis B
Published 2008-11-01Subjects: “…tenofovir…”
Get full text
Article -
163
Efficacy and safety of Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B with High Baseline Viral Load
Published 2020-07-01Subjects: “…tenofovir; hbv; alt…”
Get full text
Article -
164
-
165
Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States
Published 2022-02-01“…**Background:** While some studies among patients with HIV-1 suggest that antiretroviral therapy (ART) regimens containing tenofovir alafenamide (TAF) may be associated with greater weight gain than those not containing TAF, no studies have assessed the relationship between TAF doses and weight change. …”
Get full text
Article -
166
Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
Published 2019-09-01“…Methods A total of 334 patients who were initiated on entecavir or tenofovir between 2007 and 2016 with available TE results were recruited. …”
Get full text
Article -
167
Associations between plasma tenofovir concentration and renal function markers in HIV-infected women
Published 2016-07-01Subjects: “…Tenofovir…”
Get full text
Article -
168
[Tenofovir and entecavir for chronic hepatitis B infection treatment: a single-center experience]
Published 2015-12-01Subjects: Get full text
Article -
169
Tenofovir Alafenamide (TAF) as Long-Term Therapy for Chronic Hepatitis B: Is It the Best Choice?
Published 2022-12-01Get full text
Article -
170
Tenofovir as Rescue Therapy Following Clinical Failure to Lamivudine in Severe Acute Hepatitis B
Published 2013-06-01Subjects: Get full text
Article -
171
A Unique Case Of Tenofovir-Induced DRESS Syndrome Associated With Raynaud’s Of The Tongue
Published 2019-10-01Subjects: Get full text
Article -
172
Synthesis and Evaluation of Anti-HIV Activity of Mono- and Di-Substituted Phosphonamidate Conjugates of Tenofovir
Published 2022-07-01Subjects: Get full text
Article -
173
Cost-effectiveness of two antiviral therapies for chronic hepatitis B in Peru: entecavir and tenofovir
Published 2017-10-01“…To compare in terms of cost-effectiveness to entecavir (ETV) and tenofovir (TDF) in the treatment of hepatitis B virus (HBV) in public hospitals in Peru. …”
Get full text
Article -
174
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis
Published 2021-09-01Subjects: Get full text
Article -
175
Evaluation of cardiovascular biomarkers In HIV-infected patients switching to abacavir or tenofovir based therapy
Published 2011-10-01Subjects: Get full text
Article -
176
Síndrome general y dolores óseos en un paciente tratado con tenofovir
Published 2015-11-01Subjects: Get full text
Article -
177
Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis
Published 2018-08-01Subjects: “…Tenofovir…”
Get full text
Article -
178
Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
Published 2020-05-01“…Failure of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine may occur despite perfect adherence, although this is uncommon. …”
Get full text
Article -
179
Effectiveness and safety of tenofovir alafenamide in children and adolescents living with HIV: a systematic review
Published 2023-02-01Subjects: Get full text
Article -
180
Chitosan-Based Mucoadhesive Vaginal Tablets for Controlled Release of the Anti-HIV Drug Tenofovir
Published 2019-01-01Subjects: Get full text
Article